MECP2 MBD-ID Module: A Unified DNA/RNA Binding Interface Disrupted in Rett Syndrome

Area of Science:

• Epigenetics
• Neurodevelopmental Disorders
• Molecular Biology

Background:

• Rett syndrome is a neurodevelopmental disorder linked to mutations in the MECP2 gene.
• The MECP2 methyl-CpG binding domain (MBD) is known, but the intervening domain (ID) function is unclear.
• Conflicting data exists on ID's role in RNA binding and competition with DNA binding.

Purpose of the Study:

• To investigate the functional relationship between the MECP2 MBD and ID.
• To resolve conflicting evidence regarding MECP2's interaction with RNA and DNA.
• To establish a new model for MECP2 function based on integrated domain activity.

Main Methods:

• Biochemical assays to measure DNA and RNA binding affinities.
• Analysis of Rett syndrome-associated mutations in the MECP2 ID.
• Characterization of a therapeutic MiniGene construct.

Main Results:

• The MBD and ID function synergistically, not in isolation.
• The ID enhances MBD affinity for methylated DNA by ~35-fold.
• The MBD-ID module binds RNA with >1000-fold increased affinity compared to individual domains, precluding DNA binding.
• Rett syndrome mutations disrupt the balance of RNA and DNA binding.

Conclusions:

• The MBD-ID module is MECP2's central nucleic acid interaction hub.
• Disruption of the MBD-ID module's competitive binding explains Rett syndrome etiology.
• This provides a molecular basis for understanding MECP2-related disorders.